Tobacco control playbook

This resource highlights the arguments and approaches that leaders in health systems across Europe have developed and used to counteract and succeed against the tobacco industry. |WHO Europe

The Tobacco Control Playbook has been developed by collecting numerous evidence-based arguments from different thematic areas, reflecting the challenges that tobacco control leaders have faced while implementing various articles of the WHO FCTC and highlighting arguments they have developed in order to counter and succeed against the tobacco industry.

This is the start of what is intended to be a living document, which will be updated and extended with further arguments and on the basis of feedback, as well as any developments in tobacco industry approaches. Everyone concerned with tobacco control is invited to contribute to its success by continuing to offer arguments and responses, and sharing their experiences through a dedicated website.

Towards a smoke-free generation: tobacco control plan for England

Outlining plans to reduce smoking in England, with the aim of creating a smoke-free generation | Department of Health

non-smoking-2497308_960_720.jpg

The objectives of the tobacco control plan are to:

  • reduce the number of 15 year olds who regularly smoke from 8% to 3% or less
  • reduce smoking among adults in England from 15.5% to 12% or less
  • reduce the inequality gap in smoking prevalence, between those in routine and manual occupations and the general population
  • reduce the prevalence of smoking in pregnancy from 10.5% to 6% or less

The aim is to achieve these objectives by the end of 2022.

Full report available here

Adult smoking habits in the UK: 2016

Cigarette smoking among adults including the proportion of people who smoke including demographic breakdowns, changes over time, and e-cigarettes. | Office for National Statistics

smoke-933237_1920 (1)

Main points

  • In 2016, of all adult survey respondents in the UK, 15.8% smoked which equates to around 7.6 million in the population.
  • Of the constituent countries, 15.5% of adults in England smoked; for Wales, this figure was 16.9%; Scotland, 17.7% and Northern Ireland, 18.1%.
  • In the UK, 17.7% of men were current smokers which was significantly higher in comparison with 14.1% of women.
  • Those aged 18 to 24 in the UK experienced the largest decline in smoking prevalence of 6.5 percentage points since 2010.
  • Among current smokers in Great Britain, men smoked 12.0 cigarettes each day on average whereas women smoked 11.0 cigarettes each day on average; these are some of the lowest levels observed since 1974.
  • In Great Britain, 5.6% of respondents in 2016 stated they currently used an e-cigarette in 2016, which equates to approximately 2.9 million people in the population.

Access the full document: Adult smoking habits in the UK: 2016

Tobacco packaging design for reducing tobacco use

The Cochrane Database of Systematic Reviews has published ‘Tobacco packaging design for reducing tobacco use’.

Tobacco use is the largest single preventable cause of death and disease worldwide. Standardised tobacco packaging is an intervention intended to reduce the promotional appeal of packs and can be defined as packaging with a uniform colour (and in some cases shape and size) with no logos or branding, apart from health warnings and other government-mandated information, and the brand name in a prescribed uniform font, colour and size. Australia was the first country to implement standardised tobacco packaging between October and December 2012, France implemented standardised tobacco packaging on 1 January 2017 and several other countries are implementing, or intending to implement, standardised tobacco packaging.

The objective of the study was to assess the effect of standardised tobacco packaging on tobacco use uptake, cessation and reduction.

The available evidence suggests that standardised packaging may reduce smoking prevalence. Only one country had implemented standardised packaging at the time of this review, so evidence comes from one large observational study that provides evidence for this effect. A reduction in smoking behaviour is supported by routinely collected data by the Australian government. Data on the effects of standardised packaging on non-behavioural outcomes (e.g. appeal) are clearer and provide plausible mechanisms of effect consistent with the observed decline in prevalence. As standardised packaging is implemented in different countries, research programmes should be initiated to capture long term effects on tobacco use prevalence, behaviour, and uptake. The researchers did not find any evidence suggesting standardised packaging may increase tobacco use.

Read the full text here

Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders

The Cochrane Database of Systematic Reviews has published ‘Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders’.

Smoking rates in people with alcohol and other drug dependencies are two to four times those of the general population. Concurrent treatment of tobacco dependence has been limited due to concern that these interventions are not successful in this population or that recovery from other addictions could be compromised if tobacco cessation was combined with other drug dependency treatment.

Thirty-five randomised controlled trials, one ongoing, involving 5796 participants met the criteria for inclusion in this review. Included studies assessed the efficacy of tobacco cessation interventions, including counselling, and pharmacotherapy consisting of nicotine replacement therapy (NRT) or non-NRT, or the two combined, in both inpatient and outpatient settings for participants in treatment and in recovery.

The researchers concluded that providing tobacco cessation interventions targeted to smokers in treatment and recovery for alcohol and other drug dependencies increases tobacco abstinence. There was no evidence that providing interventions for tobacco cessation affected abstinence from alcohol and other drugs. The association between tobacco cessation interventions and tobacco abstinence was consistent for both pharmacotherapy and combined counselling and pharmacotherapy, for participants both in treatment and in recovery, and for people with alcohol dependency or other drug dependency. The evidence for the interventions was low quality due primarily to incomplete reporting of the risks of bias and clinical heterogeneity in the nature of treatment. Overall, the results suggest that tobacco cessation interventions incorporating pharmacotherapy should be incorporated into clinical practice to reduce tobacco addiction among people in treatment for or recovery from alcohol and other drug dependence.

Read more here

Local Tobacco Control Profiles – August 2016 Update

The Local Tobacco Control Profiles (LTCP) for England provide a snapshot of the extent of tobacco use, tobacco related harm, and measures being taken to reduce this harm at a local level, such as Local Stop Smoking Services.

Lung cancer registrations

Image caption: https://www.gov.uk/

These profiles have been designed to help local government and health services assess the effect of tobacco use on their local populations. The profiles also show inequalities in health between local authorities and between different population groups. They will inform commissioning and planning decisions to tackle tobacco use and improve the health of local communities.

The Annual Population Survey (APS) smoking prevalence indicators are a new set of indicators for the Local Tobacco Control Profiles. The APS is a designated National Statistic and provides a consistent time series of data.

Other indicators covered are:

  • Lung cancer registrations
  • Oral cancer registrations
  • Potential years of life lost due to smoking related illness
  • Accidental fires ignited by smoking materials and fatalities from accidental fires

Read more here

New rules on the packaging of tobacco and advertising e -cigarettes

https://www.flickr.com/photos/87735223@N02/25470325872/in/photolist-ENJ5vw-oQMp8A-tmCTC1-gVFs9c-bcgFMZ-hyh7pf-eqp1NG-r35THN-hKZ4GL-hKZKoX-du786C-CwNiuo-eiM8To-qUC8CG-nZENU5-qUBYLd-qCgSV6-FyevPH-nLeuLw-qvDBar-GkBF7P-pR1h7e-rsoRgG-hKZLxv-qSpB2b-mmT5dw-qUGRdk-qCfoFz-jEAf3V-icHgDY-k6VEhD-mF7SWi-qUGKZe-iiKkuw-pgpx7F-qoc441-qC8hzj-pXVvPn-fF831J-pjKNTa-odhndM-fn3ykJ-p2kCRk-ei1Xxy-iiN7D7-qC7YZE-q6PZZi-GtvKc6-fmNo7n-hqW2Fw

image source: Lindsay Fox Flickr – // CC BY-NC 2.0

The Department of Health has published two new guidance documents in relation to the changes of laws to the packaging and branding of tobacco products and the advertising of e-cigarettes:

  • Tobacco Packaging Guidance: This guidance provides an overview of new rules on the packaging of tobacco (and herbal products for smoking) for retail, which came into force on 20 May 2016.